The Food and Drug Administration’s approval of the abortion drug RU-486 sparked a new round of debate between pro-life and pro-choice activists, but it also brought forth a new discussion about the drug’s medical benefits and drawbacks, who will be allowed to administer it, and how states will regulate its use. A panel talks about the new concerns raised by the introduction of RU-486 in the U.S.

Guests

  • Richard Pierce professor of administrative law at George Washington University
  • Dr. Mitchell Creinin physician
  • Maxine Klane Planned Parenthood of Metropolitan Washington

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Penelope Leach: “When Parents Part”

Thursday, May 28 2015Research psychologist Penelope Leach is known for her best-selling guides on child development, including "Babyhood" and "Your Baby and Child." In her latest book, she explains what the latest research says about helping children cope with separation and divorce.